CIK 0000886163 · Large accelerated filer
LIGAND PHARMACEUTICALS INC
Sign in to watch- Tickers
- LGND LGNDZ LGNXZ LGNYZ LGNZZ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770160744
- Phone
- 858-550-7500
- Business address
- 3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
- Former names
- LIGAND PHARMACEUTICALS
Securities
- LGND Common Stock Nasdaq
- LGNDZ Common stock OTC
- LGNXZ Common stock OTC
- LGNYZ Common stock OTC
- LGNZZ Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $6,585,411
- in 7 filings, $4.5M under 10b5-1 plans
Net −$6,585,411. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-11 | KOZARICH JOHN W Director | Option exercise | +4,835 | $10.12 | $49K | 34,543 |
| 2021-05-11 | KOZARICH JOHN W Director | Shares withheld for taxes | −391 | $128.56 | $50K | 34,152 |
| 2021-05-11 | KOZARICH JOHN W Director | Option exercise · Non-Qualified Stock Option (right to buy) | −4,835 | 0 | ||
| 2021-02-22 | KOZARICH JOHN W Director | Option exercise | +2,500 | $10.12 | $25K | 29,708 |
| 2021-02-22 | KOZARICH JOHN W Director | Option exercise · Non-Qualified Stock Option (right to buy) | −2,500 | 4,835 | ||
| 2021-02-15 | Berkman Charles S SVP, Gen. Counsel & Secretary | Shares withheld for taxes | −205 | $172.46 | $35K | 28,701 |
| 2021-02-15 | Berkman Charles S SVP, Gen. Counsel & Secretary | Shares withheld for taxes | −368 | $172.46 | $63K | 28,333 |
| 2021-02-15 | Berkman Charles S SVP, Gen. Counsel & Secretary | Shares withheld for taxes | −442 | $172.46 | $76K | 27,891 |
| 2021-02-15 | FOEHR MATTHEW W President and COO | Shares withheld for taxes | −641 | $172.46 | $111K | 167,557 |
| 2021-02-15 | FOEHR MATTHEW W President and COO | Shares withheld for taxes | −1,235 | $172.46 | $213K | 166,322 |
| 2021-02-15 | FOEHR MATTHEW W President and COO | Shares withheld for taxes | −1,222 | $172.46 | $211K | 165,100 |
| 2021-02-15 | HIGGINS JOHN L Chief Executive Officer | Shares withheld for taxes | −1,204 | $172.46 | $208K | 341,856 |
| 2021-02-15 | HIGGINS JOHN L Chief Executive Officer | Shares withheld for taxes | −1,947 | $172.46 | $336K | 339,909 |
| 2021-02-15 | HIGGINS JOHN L Chief Executive Officer | Shares withheld for taxes | −2,061 | $172.46 | $355K | 337,848 |
| 2021-02-15 | Korenberg Matthew E EVP,Finance & Strategy and CFO | Shares withheld for taxes | −434 | $172.46 | $75K | 41,318 |
| 2021-02-15 | Korenberg Matthew E EVP,Finance & Strategy and CFO | Shares withheld for taxes | −906 | $172.46 | $156K | 40,412 |
| 2021-02-15 | Korenberg Matthew E EVP,Finance & Strategy and CFO | Shares withheld for taxes | −969 | $172.46 | $167K | 39,443 |
| 2021-02-11 | Davis Todd C Director | Option exercise | +2,474 | $195.91 | $485K | 50,152 |
| 2021-02-11 | Davis Todd C Director | Option exercise · Non-Qualified Stock Option (right to buy) | −2,474 | 0 | ||
| 2021-02-10 | Davis Todd C Director | Sale | −5,083 | $213.14 | $1.1M | 47,678 |
Page 34 of 43 · 858 trades